Dexcom Posts 11% Sales Growth and Announces $1 Billion Buyback
Dexcom reported higher third-quarter revenue and adjusted earnings, while raising its full-year sales outlook to $5.20 billion to $5.25 billion.
Makkler Newsroom · Oct 30, 11:05 PM · 1 min read